These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37510657)

  • 1. Examining the Psychoactive Differences between Kratom Strains.
    Huisman G; Menke M; Grundmann O; Schreiber R; Mason N
    Int J Environ Res Public Health; 2023 Jul; 20(14):. PubMed ID: 37510657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.
    Lydecker AG; Sharma A; McCurdy CR; Avery BA; Babu KM; Boyer EW
    J Med Toxicol; 2016 Dec; 12(4):341-349. PubMed ID: 27752985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of kratom (Mitragyna speciosa Korth.) tea bag preparations and reported pharmacological effects.
    Grundmann O; Hill K; Al Barzanji E; Hazrat NG; Kaur G; Negeve RE; Shade S; Weber S; Veltri CA
    J Ethnopharmacol; 2023 Dec; 317():116779. PubMed ID: 37364801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products.
    Fowble KL; Musah RA
    Forensic Sci Int; 2019 Jun; 299():195-202. PubMed ID: 31059866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions.
    Todd DA; Kellogg JJ; Wallace ED; Khin M; Flores-Bocanegra L; Tanna RS; McIntosh S; Raja HA; Graf TN; Hemby SE; Paine MF; Oberlies NH; Cech NB
    Sci Rep; 2020 Nov; 10(1):19158. PubMed ID: 33154449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kratom (Mitragyna speciosa) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products.
    Manwill PK; Flores-Bocanegra L; Khin M; Raja HA; Cech NB; Oberlies NH; Todd DA
    Planta Med; 2022 Aug; 88(9-10):838-857. PubMed ID: 35468648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry.
    Sharma A; Kamble SH; León F; Chear NJ; King TI; Berthold EC; Ramanathan S; McCurdy CR; Avery BA
    Drug Test Anal; 2019 Aug; 11(8):1162-1171. PubMed ID: 30997725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance.
    Zhang M; Sharma A; León F; Avery B; Kjelgren R; McCurdy CR; Pearson BJ
    PLoS One; 2022; 17(4):e0259326. PubMed ID: 35472200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
    Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
    J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kratom (Mitragyna speciosa): worldwide issues.
    Ramanathan S; McCurdy CR
    Curr Opin Psychiatry; 2020 Jul; 33(4):312-318. PubMed ID: 32452943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of ELISA for screening of Kratom (Mitragyna speciosa) habitual users using urinary AZ122 biomarker.
    Jasim RK; Singh D; Gam LH
    Biotechnol Appl Biochem; 2023 Apr; 70(2):707-715. PubMed ID: 35931067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated Solvent Extractions (ASE) of
    Goh YS; Karunakaran T; Murugaiyah V; Santhanam R; Abu Bakar MH; Ramanathan S
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34204457
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats.
    Avery BA; Boddu SP; Sharma A; Furr EB; Leon F; Cutler SJ; McCurdy CR
    Planta Med; 2019 Mar; 85(4):340-346. PubMed ID: 30452072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis of kratom opioids.
    Kim K; Shahsavarani M; Garza-García JJO; Carlisle JE; Guo J; De Luca V; Qu Y
    New Phytol; 2023 Oct; 240(2):757-769. PubMed ID: 37518950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kratom policy: The challenge of balancing therapeutic potential with public safety.
    Prozialeck WC; Avery BA; Boyer EW; Grundmann O; Henningfield JE; Kruegel AC; McMahon LR; McCurdy CR; Swogger MT; Veltri CA; Singh D
    Int J Drug Policy; 2019 Aug; 70():70-77. PubMed ID: 31103778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do You Get What You Paid For? An Examination of Products Advertised as Kratom.
    Griffin OH; Daniels JA; Gardner EA
    J Psychoactive Drugs; 2016; 48(5):330-335. PubMed ID: 27669103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro evaluation of kratom (Mitragyna speciosa) on the catalytic activity of carboxylesterase 1 (CES1).
    Melchert PW; Zhang Q; Mukhopadhyay S; Kanumuri SRR; McCurdy CR; Markowitz JS
    Chem Biol Interact; 2023 Oct; 384():110715. PubMed ID: 37716419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants.
    Wang M; Carrell EJ; Ali Z; Avula B; Avonto C; Parcher JF; Khan IA
    J Sep Sci; 2014 Jun; 37(12):1411-8. PubMed ID: 24659356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating health information provided to kratom consumers by good manufacturing practice-qualified vendors.
    Hill K; Gibson S; Grundmann O; Smith KE; Ballard J; Stanciu CN
    Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):21. PubMed ID: 37041624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Physiologically Based Pharmacokinetic Model of Mitragynine, Psychoactive Alkaloid in Kratom (
    Ya K; Methaneethorn J; Tran QB; Trakulsrichai S; Wananukul W; Lohitnavy M
    J Psychoactive Drugs; 2021; 53(2):127-139. PubMed ID: 34003732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.